By the time you feel inflammation, it's been burning for years. That single line from the corpus reframes this entire panel. The markers in this chapter are not symptom-trackers — they are the dashboard that reads the fire before it reaches the gauges you can feel. Run a peptide protocol without them and you're driving without a dashboard. These markers map directly to systemic inflammation and iron-driven oxidative stress — two of the slow burns conventional medicine writes off as the "managed decline" of aging. They are not inevitable. They are measurable, and they move.
What's actually happening
hs-CRP is the single most useful systemic-inflammation marker you can pull, and the reason is mechanistic: it sits directly downstream of the cytokine IL-6. When tissue is inflamed — gut, vasculature, joint, anywhere — IL-6 rises, the liver responds, and hs-CRP climbs as a faithful proxy for that upstream cytokine signal. That makes it a leading indicator of vascular and metabolic trouble: the corpus is explicit that CRP is tightly linked to heart-disease risk and that post-heart-attack outcomes track CRP levels. You are reading the cytokine load of the whole body off one number.
The trap with hs-CRP is its non-specificity. It rises for infection and for recent injury or surgery — elevated by definition for 7–10 days post-injury — so a draw inside that window tells you about the wound, not your baseline. For peptide users this cuts two ways. If you're running a healing protocol after an acute injury, hs-CRP is expected to fall faster than the natural post-injury curve — that accelerated drop is your signal the protocol is working. But an hs-CRP stuck elevated past the acute window is the red flag: the inflammation isn't resolving on schedule, and that's where you intervene.
Homocysteine is the second pillar, and its danger is that it's destructive well inside the "normal" range. The corpus is clear: inflammation associations and accelerated cognitive-decline associations climb across the upper normal range long before the lab flags it. The lab's reference range is not your target — the upper-normal zone is already costing you. The lever here is methylation: homocysteine responds to methylated B-vitamin support — methylfolate, methyl-B12, and B6. Fibrinogen belongs in the same conversation; it's an inflammation-and-clotting marker that responds to the same methylated B-vitamin support and is worth interpreting alongside hs-CRP rather than in isolation. Read the three together and you get a coherent picture of systemic inflammatory tone.
Then there's ferritin — the marker that lives on both sides of the line. It is the iron-storage protein and an acute-phase reactant simultaneously, which means a single ferritin value can mean two opposite things. A high ferritin can be abundant iron stores, or it can be inflammation driving the number up while iron availability is actually poor. This is why ferritin is never read alone. The disambiguation comes from pairing it with transferrin saturation (TSAT) and hs-CRP:
- Low TSAT + low ferritin = true iron deficiency.
- Low TSAT + high/normal ferritin + high hs-CRP = inflammation sequestering iron — the stores look fine on paper but the iron isn't reaching erythropoiesis.
TSAT below ~20% signals iron-deficient erythropoiesis — poor iron availability — even when ferritin looks adequate. TSAT is the calculated ratio of serum iron over TIBC. TIBC (total iron-binding capacity) is effectively a proxy for transferrin concentration and serves as the denominator in that saturation math; it's more stable than serum iron, which swings. Pull serum iron and TIBC together on the fasting AM iron panel so the calculated TSAT is internally consistent — serum iron drifts through the day and with recent supplementation, so a sloppy draw poisons the ratio.
The other end of ferritin matters for peptide users specifically. In men, ferritin above ~150–200 begins to track with iron-driven oxidative inflammation — men don't menstruate, so iron accumulates with nowhere to go, and stored iron becomes a rusting, pro-oxidant load. In women, the symptomatic-deficiency zone — fatigue, hair loss, poor recovery — commonly appears below ~40–50 even when the lab calls it normal. And there's a protocol-relevant interaction: the TRT / androgen iron-utilization caveat applies — any androgen pulls on iron utilization, so TRT users should read their iron panel knowing the demand side has shifted.
The panel that matters
| Marker | Optimal / threshold (substrate) | Timing | Notes |
|---|---|---|---|
| hs-CRP | Lower is better; flag if stuck elevated past 7–10d post-injury window | Avoid drawing within 7–10d of injury/surgery/infection | Downstream of IL-6; on a healing protocol expect it to fall faster than the natural post-injury curve |
| Homocysteine | Target the lower end — upper-normal already carries risk | Standard fasting draw | Responds to methylfolate, methyl-B12, B6 |
| Fibrinogen | Interpret alongside hs-CRP | Standard draw | Methylated B-vitamin responsive; inflammation + clotting marker |
| Ferritin (male) | ~150–200 upper bound before oxidative-inflammation tracking | No strict fasting requirement; pull with fasting panel | Dual marker — never read alone |
| Ferritin (female) | Symptomatic deficiency commonly <40–50 even when "normal" | Note menstrual/cycle status on the draw | Dual marker — pair with TSAT + hs-CRP |
| Serum Iron | Read only via TSAT, not alone | Fasting AM; no iron supplement before draw | Swings intraday and with supplementation |
| TIBC | Denominator for TSAT; transferrin proxy | Fasting AM panel | More stable than serum iron |
| TSAT | <20% = iron-deficient erythropoiesis | Fasting AM panel | The availability marker — disambiguates ferritin |
| Uric Acid | — | Fasting draw preferred; hydrate; avoid recent high-purine meal or alcohol | Transiently raised by purine load/alcohol |
Compound protocols for lowering hs-CRP or homocysteine directly are not the subject of this chapter, and the practitioner corpus here is thin on peptide-specific dosing for these two markers — track the markers, run your protocol, and watch the trajectory rather than chasing a single draw.
What's NOT happening yet
- One draw is not a trend. A single ferritin value is ambiguous by design — it can mean abundance or inflammation-driven sequestration. You don't know which until you pair it with TSAT and hs-CRP. Don't act on a lone number.
- A "normal" homocysteine is not an optimal one. Risk climbs across the upper-normal range before the lab flags anything. Inside-range is not the same as done.
- An elevated hs-CRP right after injury is not a problem — yet. Inside the 7–10 day post-injury window it's expected. The signal is whether it's still elevated after that window closes.
- A high ferritin is not proof of good iron status. If TSAT is low and hs-CRP is high, your iron is sequestered, not available — the stores number is lying to you.
- You should not be drawing blood every seven minutes. You manage what you measure, but reactive over-testing just adds noise. This panel is a quarterly-to-protocol-paced dashboard, not a daily metric.
The research describes these ranges and relationships. Pull the panel, read the markers together, and adjust.